2023-505335-12-00撤回4 期
Open label, four-period, two-sequence, fully replicated, randomized, single dose pivotal study for the assessment of bioequivalence between Furosemide 500 mg tablets (Test) and Lasix 500 mg tablets (Reference) in healthy male volunteers under fasting conditions
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 入组人数
- 50
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Constanze Scheel
Scientific
Ratiopharm GmbH
研究点 (1)
Loading locations...
相似试验
已完成
4 期
OPEN LABEL, FOUR-PERIOD, TWO-SEQUENCE, FULLY-REPLICATED, RANDOMIZED, SINGLE DOSE COMPARATIVE STUDY TO ASSESS BIOEQUIVALENCE OF Polypill AAR 100/80/10 mg capsules FIXED DOSE COMBINATION (TEST) VERSUS EQUAL DOSES OF COADMINISTERED Aspirin® N 100mg tablets + Cardyl® 80mg film-coated tablets + Acovil® 10mg tablets (REFERENCE formulations) IN HEALTHY MALE AND FEMALE VOLUNTEERS UNDER FASTING CONDITIONS2023-505572-30-00Ferrer Internacional S.A.56
已完成
Unknown
A Study to Evaluate the Safety and Bioequivalence of AD-201 Compared to Coadministration of AD-2011 and AD-2012Diseases of the circulatory systemKCT0009387Addpharma58
已完成
4 期
An open label, randomized, four-period, four-sequence single dose, crossover trial in healthy volunteers to determine the relative bioavailability of Dimenhydrinate 50 mg (Test) administered with and without water vs. Vomex A 50 mg Lösung zum Einnehmen im Beutel (Reference 1) and Biodramina 50 mg Comprimidos (Reference 2)2022-502420-51-00CCDRD Cooperative Clinical Drug Research and Development AG, Hermes Pharma GmbH14
已完成
4 期
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Valacyclovir Oral Suspension compared to Valtrex® Tablets in normal, healthy subjects under fasting conditions.2024-511570-77-00Dermax30
进行中（未招募）
1 期
Study to compare the pharmacokinetics of mometasone furoate alone and in combination with indacaterol in patients = 6 to < 12 years old with asthmaAsthma in pediatric patientsMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2020-002036-78-HUovartis Pharma AG32